Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older.
aDepartment of Infectious Diseases bShaanxi Provincial Clinical Research Center for Hepatic and Splenic Diseases cNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China dDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.
Fanpu
F
Ji
Changyin
C
Tian
Zongfang
Z
Li
Hong
H
Deng
Mindie H
MH
Nguyen
D016174:Hepacivirus; D006801:Humans; D000069474:Sofosbuvir
D000069474:Sofosbuvir